Characterization of Children With Recurrent Episodes of Stevens Johnson Syndrome

Daniel Olson1,2, Jordan Abbott3, Clara Lin1

  • 1University of Colorado School of Medicine, Aurora.

Insights

Recurrent Stevens Johnson Syndrome (SJS) in children often involves mucus membranes with minimal skin issues. Mycoplasma infections and specific genetic markers like HLA-B27 are frequently observed in these cases.

Area of Science:

  • Pediatric Dermatology
  • Immunology
  • Infectious Diseases

Background:

  • Recurrent Stevens Johnson Syndrome (SJS) is a severe mucocutaneous reaction.
  • Understanding triggers and characteristics of recurrent SJS in pediatric populations is crucial.

Purpose of the Study:

  • To analyze the clinical features and potential associations of recurrent Stevens Johnson Syndrome (SJS) in children.
  • To identify commonalities among pediatric patients experiencing repeated SJS episodes.

Main Methods:

  • Retrospective chart review of pediatric patients diagnosed with recurrent SJS.
  • Data collection spanned from March 2013 to March 2016.
  • Analysis focused on patient demographics, clinical presentation, and associated factors.

Main Results:

  • Nine male children experienced 29 episodes of SJS or incomplete SJS.
  • The majority (88%) of patients were white.
  • Episodes predominantly affected mucous membranes with limited skin involvement.
  • Mycoplasma infections and HLA-B27/-B51 genetic markers were frequently identified.

Conclusions:

  • Recurrent SJS in children presents with characteristic mucocutaneous involvement.
  • Mycoplasma infections and specific HLA types may predispose children to recurrent SJS.
  • Further research into the immunological and infectious underpinnings of recurrent SJS is warranted.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
342
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
303
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
75
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
3.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
503
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
78